Abstract
Condition: Relapsing Multiple Sclerosis
Interventions: Other: Ofatumumab; Other: Covid-19 vaccine
Sponsor: Novartis Pharmaceuticals
Not yet recruiting
ID: 48
Discovery Date: 19 April 2021, 11:50:37 UTC
Published Date: 2021-04-19 16:00:00
Source: Clinical Trials.gov
Link: https://clinicaltrials.gov/ct2/show/NCT04847596?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14